These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2181745)

  • 1. Australian frozen vaccines for the control of babesiosis and anaplasmosis in cattle--a review.
    Dalgliesh RJ; Jorgensen WK; de Vos AJ
    Trop Anim Health Prod; 1990 Feb; 22(1):44-52. PubMed ID: 2181745
    [No Abstract]   [Full Text] [Related]  

  • 2. Post-thawing viability of vaccines for bovine babesiosis and anaplasmosis cryopreserved with glycerol.
    Mangold AJ; Aguirre DH; Guglielmone AA
    Vet Parasitol; 1990 Nov; 37(3-4):301-6. PubMed ID: 2267730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of cattle with an inactivated polyvalent vaccine against anaplasmosis and babesiosis.
    Montenegro-James S; Toro M; Leon E; Guillen AT; Lopez R; Lopez W
    Ann N Y Acad Sci; 1992 Jun; 653():112-21. PubMed ID: 1626861
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunisation of smallholder dairy cattle against anaplasmosis and babesiosis in Malawi.
    Tjornehoj K; Lawrence JA; Kafuwa PT; Whiteland AP; Chimera BA
    Trop Anim Health Prod; 1997 May; 29(2):77-82. PubMed ID: 9203307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collection and sterilization of large volumes of bovine serum and its use in vaccines against bovine babesiosis and anaplasmosis.
    Rodwell BJ; Timms P; Parker RJ
    Aust J Exp Biol Med Sci; 1980 Apr; 58(2):143-7. PubMed ID: 7436873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods currently used for the control of anaplasmosis and babesiosis: their validity and proposals for future control strategies.
    Lawrence JA; de Vos AJ
    Parassitologia; 1990 Apr; 32(1):63-71. PubMed ID: 2284136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of tetracycline and Babesia culture supernatant as prophylactics for moderating reactions in cattle to live Babesia and Anaplasma vaccines.
    Jorgensen WK; Bock RE; Kingston TG; de Vos AJ; Waldron SJ
    Aust Vet J; 1993 Jan; 70(1):35-6. PubMed ID: 8460988
    [No Abstract]   [Full Text] [Related]  

  • 8. Attenuated trivalent vaccine against babesiosis and anaplasmosis in Colombia.
    Benavides E; Vizcaino O; Britto CM; Romero A; Rubio A
    Ann N Y Acad Sci; 2000; 916():613-6. PubMed ID: 11193685
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging perspectives in the research of bovine babesiosis and anaplasmosis.
    Suarez CE; Noh S
    Vet Parasitol; 2011 Aug; 180(1-2):109-25. PubMed ID: 21684084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of the potential demand for a bovine babesiosis and anaplasmosis vaccine in Argentina.
    Späth EJ; Mangold AJ; Guglielmone AA
    Vet Parasitol; 1990 May; 36(1-2):131-40. PubMed ID: 2382381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tick-borne diseases of cattle in Paraguay. II. Immunisation against anaplasmosis and babesiosis.
    Payne RC; Osorio O; Ybañez A
    Trop Anim Health Prod; 1990 May; 22(2):101-8. PubMed ID: 2196724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines against hemoparasitic diseases in Israel with special reference to quality assurance.
    Pipano E
    Trop Anim Health Prod; 1997 Nov; 29(4 Suppl):86S-90S. PubMed ID: 9512751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis for vaccine development against anaplasmosis and babesiosis.
    Palmer GH; McElwain TF
    Vet Parasitol; 1995 Mar; 57(1-3):233-53. PubMed ID: 7597787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a frozen trivalent attenuated vaccine against Babesiosis and anaplasmosis in Brazil.
    Vidotto O; Barbosa CS; Andrade GM; Machado RZ; da Rocha MA; Silva SS
    Ann N Y Acad Sci; 1998 Jun; 849():420-3. PubMed ID: 9668502
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the infectivity of Babesia bovis, Babesia bigemina and Anaplasma centrale for cattle after cryopreservation in either dimethylsulphoxide (DMSO) or polyvinylpyrrolidone (PVP).
    Standfast NF; Jorgensen WK
    Aust Vet J; 1997 Jan; 75(1):62-3. PubMed ID: 9034504
    [No Abstract]   [Full Text] [Related]  

  • 16. The safety and efficacy of Australian tick-borne disease vaccine strains in cattle in Paraguay.
    Brizuela CM; Ortellado CA; Sanabria E; Torres O; Ortigosa D
    Vet Parasitol; 1998 Mar; 76(1-2):27-41. PubMed ID: 9653988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunodiagnosis of and immunoprophylaxis against the haemoparasites Babesia sp. and Anaplasma sp. in domestic animals.
    Wright IG
    Rev Sci Tech; 1990 Jun; 9(2):345-56. PubMed ID: 2132684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization against anaplasmosis and babesiosis: Part I. Evaluation of immunization using minimum infective doses under laboratory conditions.
    González EF; Todorovic RA; Thompson KC
    Tropenmed Parasitol; 1976 Dec; 27(4):427-37. PubMed ID: 1006801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity following use of Australian tick fever vaccine: a review of the evidence.
    Bock RE; de Vos AJ
    Aust Vet J; 2001 Dec; 79(12):832-9. PubMed ID: 11837905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observations on the use of Anaplasma centrale for immunization of cattle against anaplasmosis in Zimbabwe.
    Turton JA; Katsande TC; Matingo MB; Jorgensen WK; Ushewokunze-Obatolu U; Dalgliesh RJ
    Onderstepoort J Vet Res; 1998 Jun; 65(2):81-6. PubMed ID: 9741051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.